Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
December-2016 Volume 14 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2016 Volume 14 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production

  • Authors:
    • Zhenxing He
    • Xuanfei Li
    • Hao Chen
    • Kun He
    • Yiming Liu
    • Junhua Gong
    • Jianping Gong
  • View Affiliations / Copyright

    Affiliations: Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China
  • Pages: 5595-5600
    |
    Published online on: November 15, 2016
       https://doi.org/10.3892/mmr.2016.5943
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Inflammation and oxidative stress serve an important role in the development of lipopolysaccharide/D-galactosamine (LPS/GalN)‑induced acute liver injury. Nobiletin, which is found in high quantities in the peel of citrus fruits, is able to modulate immune responses, including inflammatory response and oxidative stress. The present study aimed to evaluate the protective effects of nobiletin on LPS/GalN‑induced acute liver injury. Male C57BL/6 mice were intraperitoneally treated with nobiletin (50, 100 and 200 mg/kg) 2 h prior to LPS/GalN injection. Liver injury was observed in the LPS/GalN group, as demonstrated by increased levels of serum hepatic enzymes and hepatic inflammatory mediators, as well as by histopathological alterations. Treatment with nobiletin reduced serum alanine aminotransferase and aspartate aminotransferase levels, improved hepatic structure, and suppressed hepatic interleukin (IL)‑1β, IL‑6 and tumor necrosis factor‑α production 24 h after LPS/GalN exposure. Western blot analysis revealed that nobiletin treatment inhibited inducible nitric oxide synthase and cyclooxygenase‑2 liver expression. In addition, nobiletin suppressed LPS/GalN‑induced phosphorylation and degradation of inhibitor of nuclear factor (NF)‑κB (IκB)α, as well as NF‑κB p65 translocation into the nucleus. Nobiletin also upregulated the expression of nuclear NF‑E2‑related factor 2 (Nrf2) and cytoplasmic heme oxygenase‑1. In conclusion, these results indicate that nobiletin serves a protective role in LPS/GalN‑induced acute liver injury via activation of the Nrf2 antioxidant pathway and subsequent inhibition of NF‑κB‑mediated cytokine production. These findings support the potential for nobiletin as a therapeutic agent for the treatment of acute liver injury.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Pierre PG, Solbreux P and Vaerman JP: Cholera toxin-induced fluid secretion in rat gut ligated loops: Influence of bile from normal or cholera toxin-immunized rats. Immunology. 68:319–324. 1989.PubMed/NCBI

2 

Forbes SJ, Gupta S and Dhawan A: Cell therapy for liver disease: From liver transplantation to cell factory. J Hepatol. 62:(Suppl 1). S157–S169. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Bernal W, Lee WM, Wendon J, Larsen FS and Williams R: Acute liver failure: A curable disease by 2024? J Hepatol. 62:(Suppl 1). S112–S120. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Kuroda N, Inoue K, Ikeda T, Hara Y, Wake K and Sato T: Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition. PLoS One. 9:e928842014. View Article : Google Scholar : PubMed/NCBI

5 

Shukla P, Rao GM, Pandey G, Sharma S, Mittapelly N, Shegokar R and Mishra PR: Therapeutic interventions in sepsis: Current and anticipated pharmacological agents. Br J Pharmacol. 171:5011–5031. 2014.PubMed/NCBI

6 

Tsutsui H and Nishiguchi S: Importance of Kupffer cells in the development of acute liver injuries in mice. Int J Mol Sci. 15:7711–7730. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Moratalla A, Caparrós E, Juanola O, Portune K, Puig-Kröger A, Estrada-Capetillo L, Bellot P, Gómez-Hurtado I, Piñero P, Zapater P, et al: Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis. J Hepatol. 64:135–145. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Nakajima A, Ohizumi Y and Yamada K: Anti-dementia activity of nobiletin, a citrus flavonoid: A review of animal studies. Clin Psychopharmacol Neurosci. 12:75–82. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Xiu LJ, Sun DZ, Jiao JP, Yan B, Qin ZF, Liu X, Wei PK and Yue XQ: Anticancer effects of traditional Chinese herbs with phlegm-eliminating properties-An overview. J Ethnopharmacol. 172:155–161. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Horigome S, Yoshida I, Tsuda A, Harada T, Yamaguchi A, Yamazaki K, Inohana S, Isagawa S, Kibune N, Satoyama T, et al: Identification and evaluation of anti-inflammatory compounds from Kaempferia parviflora. Biosci Biotechnol Biochem. 78:851–860. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Malik S, Bhatia J, Suchal K, Gamad N, Dinda AK, Gupta YK and Arya DS: Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects. Exp Toxicol Pathol. 67:427–433. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Choi BK, Kim TW, Lee DR, Jung WH, Lim JH, Jung JY, Yang SH and Suh JW: A polymethoxy flavonoids-rich Citrus aurantium extract ameliorates ethanol-induced liver injury through modulation of AMPK and Nrf2-related signals in a binge drinking mouse model. Phytother Res. 29:1577–1584. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Tominari T, Hirata M, Matsumoto C, Inada M and Miyaura C: Polymethoxy flavonoids, nobiletin and tangeretin, prevent lipopolysaccharide-induced inflammatory bone loss in an experimental model for periodontitis. J Pharmacol Sci. 119:390–394. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Mair F, Joller S, Hoeppli R, Onder L, Hahn M, Ludewig B, Waisman A and Becher B: The NF kappa B-inducing kinase is essential for the developmental programming of skin-resident and IL-17-producing gamma delta T cells. eLife. 4:e100872015. View Article : Google Scholar : PubMed/NCBI

15 

Lu MC, Ji JA, Jiang ZY and You QD: The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update. Med Res Rev. 36:924–963. 2016. View Article : Google Scholar : PubMed/NCBI

16 

van Beek JH, de Moor MH, de Geus EJ, Lubke GH, Vink JM, Willemsen G and Boomsma DI: The genetic architecture of liver enzyme levels: GGT, ALT and AST. Behav Genet. 43:329–339. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Liang DY, Liu LM, Ye CG, Zhao L, Yu FP, Gao DY and Wang YY, Yang ZW and Wang YY: Inhibition of UII/UTR system relieves acute inflammation of liver through preventing activation of NF-kappaB pathway in ALF mice. PLoS One. 8:e648952014. View Article : Google Scholar : PubMed/NCBI

18 

Liu LM, Liang DY, Ye CG, Tu WJ and Zhu T: The UII/UT system mediates upregulation of proinflammatory cytokines through p38 MAPK and NF-κB pathways in LPS-stimulated Kupffer cells. PLoS One. 10:e01213832015. View Article : Google Scholar : PubMed/NCBI

19 

Yang P, Zhou W, Li C, Zhang M, Jiang Y, Jiang R, Ba H, Li C, Wang J, Yin B, et al: Kupffer-cell-expressed transmembrane TNF-α is a major contributor to lipopolysaccharide and D-galactosamine-induced liver injury. Cell Tissue Res. 363:371–383. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Ahmad A, Raish M, Ganaie MA, Ahmad SR, Mohsin K, Al-Jenoobi FI, Al-Mohizea AM and Alkharfy KM: Hepatoprotective effect of Commiphora myrrha against d-GalN/LPS-induced hepatic injury in a rat model through attenuation of pro inflammatory cytokines and related genes. Pharm Biol. 53:1759–1767. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Ma L, Gong X, Kuang G, Jiang R, Chen R and Wan J: Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice. Biochem Biophys Res Commun. 461:230–236. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Yamada Y, Ishizaki M, Kido T, Honda R, Tsuritani I, Nogawa K and Yamaya H: Relationship between serum gamma-glutamyl transpeptidase activity, blood pressure and alcohol consumption. J Hum Hypertens. 3:409–417. 1989.PubMed/NCBI

23 

Cordero-Coma M and Sobrin L: Anti-tumor necrosis factor-alpha therapy in uveitis. Surv Ophthalmol. 60:575–589. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Ma Z, Hou T, Shi W, Liu W and He H: Inhibition of hepatocyte apoptosis: An important mechanism of corn peptides attenuating liver injury induced by ethanol. Int J Mol Sci. 16:22062–22080. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Peixoto CA and Gomes FO: The role of phosphodiesterase-5 inhibitors in prostatic inflammation: A review. J Inflamm (Lond). 12:542015. View Article : Google Scholar : PubMed/NCBI

26 

Sun J, Zhang S, Zhang X, Zhang X, Dong H and Qian Y: IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation. J Neuroinflammation. 12:1652015. View Article : Google Scholar : PubMed/NCBI

27 

Li J, Zhang X and Huang H: Protective effect of linalool against lipopolysaccharide/D-galactosamine-induced liver injury in mice. Int Immunopharmacol. 23:523–529. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Senegas A, Gautheron J, Maurin AG and Courtois G: IKK-related genetic diseases: Probing NF-κB functions in humans and other matters. Cell Mol Life Sci. 72:1275–1287. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Verstrepen L and Beyaert R: Receptor proximal kinases in NF-κB signaling as potential therapeutic targets in cancer and inflammation. Biochem Pharmacol. 92:519–529. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Muriach M, Flores-Bellver M, Romero FJ and Barcia JM: Diabetes and the brain: Oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev. 2014:1021582014. View Article : Google Scholar : PubMed/NCBI

31 

Dodson M, Redmann M, Rajasekaran NS, Darley-Usmar V and Zhang J: KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity. Biochem J. 469:347–355. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Jiménez-Osorio AS, González-Reyes S and Pedraza-Chaverri J: Natural Nrf2 activators in diabetes. Clin Chim Acta. 448:182–192. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Hahn ME, Timme-Laragy AR, Karchner SI and Stegeman JJ: Nrf2 and Nrf2-related proteins in development and developmental toxicity: Insights from studies in zebrafish (Danio rerio). Free Radic Biol Med. 88:275–289. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Kanninen KM, Pomeshchik Y, Leinonen H, Malm T, Koistinaho J and Levonen AL: Applications of the Keap1-Nrf2 system for gene and cell therapy. Free Radic Biol Med. 88:350–361. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Buelna-Chontal M and Zazueta C: Redox activation of Nrf2 & NF-κB: A double end sword? Cell Signal. 25:2548–2557. 2013. View Article : Google Scholar : PubMed/NCBI

36 

Agca CA, Tuzcu M, Hayirli A and Sahin K: Taurine ameliorates neuropathy via regulating NF-κB and Nrf2/HO-1 signaling cascades in diabetic rats. Food Chem Toxicol. 71:116–121. 2014. View Article : Google Scholar : PubMed/NCBI

37 

Jiang T, Tian F, Zheng H, Whitman SA, Lin Y, Zhang Z, Zhang N and Zhang DD: Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response. Kidney Int. 85:333–343. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
He Z, Li X, Chen H, He K, Liu Y, Gong J and Gong J: Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production. Mol Med Rep 14: 5595-5600, 2016.
APA
He, Z., Li, X., Chen, H., He, K., Liu, Y., Gong, J., & Gong, J. (2016). Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production. Molecular Medicine Reports, 14, 5595-5600. https://doi.org/10.3892/mmr.2016.5943
MLA
He, Z., Li, X., Chen, H., He, K., Liu, Y., Gong, J., Gong, J."Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production". Molecular Medicine Reports 14.6 (2016): 5595-5600.
Chicago
He, Z., Li, X., Chen, H., He, K., Liu, Y., Gong, J., Gong, J."Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production". Molecular Medicine Reports 14, no. 6 (2016): 5595-5600. https://doi.org/10.3892/mmr.2016.5943
Copy and paste a formatted citation
x
Spandidos Publications style
He Z, Li X, Chen H, He K, Liu Y, Gong J and Gong J: Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production. Mol Med Rep 14: 5595-5600, 2016.
APA
He, Z., Li, X., Chen, H., He, K., Liu, Y., Gong, J., & Gong, J. (2016). Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production. Molecular Medicine Reports, 14, 5595-5600. https://doi.org/10.3892/mmr.2016.5943
MLA
He, Z., Li, X., Chen, H., He, K., Liu, Y., Gong, J., Gong, J."Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production". Molecular Medicine Reports 14.6 (2016): 5595-5600.
Chicago
He, Z., Li, X., Chen, H., He, K., Liu, Y., Gong, J., Gong, J."Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production". Molecular Medicine Reports 14, no. 6 (2016): 5595-5600. https://doi.org/10.3892/mmr.2016.5943
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team